|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 148.87 USD | -1.29% |
|
+4.27% | +404.82% |
| 09-03 | Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line Rating | MT |
| 09-03 | Wall Street's Triple Squeeze |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MODERNA, INC. | Biopharmaceuticals | -1.29% | +4.27% | +404.82% | +519.00% | -64.27% | 60.21B |  | | |
- Stock Market
- Stocks
- MRNA Stock
- Charts Moderna, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
